Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

Lung cancer is a leading cause of cancer-related deaths worldwide. Non-small cell lung
cancer (NSCLC) accounts for the major portion (80–85%) of all lung cancer cases …

The unequal distribution of medical resources and scarcity of experienced practitioners
confine access to bronchoscopy primarily to well-equipped hospitals in developed regions …

Introduction The incidence and mortality of lung cancer are highest in Asia compared with
Europe and USA, with the incidence and mortality rates being 34.4 and 28.1 per 100,000 …

Introduction Most published guidelines for genomic biomarker testing in NSCLC reflect the
disease epidemiology and treatments readily available in Europe and North America …

Background Lung cancer is a significant health concern in China. There is limited available
data of its burden and trends. This study aims to evaluate the trends of lung cancer across …

The escalating global threat of climate change is becoming more evident. The climate crisis
intersects with another major challenge: lung cancer. With Asia already bearing half the …

In the process of developing artificial consciousness to mimic human intelligence, situational
decision making, and self realization, steadfast progress has been noted in the field of …

Lung cancer varies between Caucasians and Asians. There have been differences recorded
in the epidemiology, genomics, standard therapies and outcomes, with variations according …

Background: MicroRNAs (miRNAs) play an important regulatory role and serve as
biomarkers in various human cancers. However, their role in the prognosis and predicting …